CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-14 | Wu Xiaobin President and COO | Sale 10b5-1 | −8,522 | $305.48 | $2.6M | 17,749 |
| 2025-08-14 | Wu Xiaobin President and COO | Sale 10b5-1 | −12,232 | $306.26 | $3.7M | 5,517 |
| 2025-08-14 | Wu Xiaobin President and COO | Sale 10b5-1 | −4,917 | $307.43 | $1.5M | 600 |
| 2025-08-14 | Wu Xiaobin President and COO | Sale 10b5-1 | −600 | $308.03 | $185K | 0 |
| 2025-08-14 | Wu Xiaobin President and COO | Option exercise · Share Option (Right to Buy) 10b5-1 | −399,828 | 309,881 | ||
| 2025-08-14 | Wu Xiaobin President and COO | Option exercise · Share Option (Right to Buy) 10b5-1 | −119,340 | 358,046 | ||
| 2025-08-13 | Wu Xiaobin President and COO | Option exercise 10b5-1 | +22,773 | $174.43 | $4.0M | 22,773 |
| 2025-08-13 | Wu Xiaobin President and COO | Option exercise 10b5-1 | +27,085 | $155.68 | $4.2M | 49,858 |
| 2025-08-13 | Wu Xiaobin President and COO | Sale 10b5-1 | −8,900 | $300.33 | $2.7M | 40,958 |
| 2025-08-13 | Wu Xiaobin President and COO | Sale 10b5-1 | −4,500 | $301.49 | $1.4M | 36,458 |
| 2025-08-13 | Wu Xiaobin President and COO | Sale 10b5-1 | −5,800 | $302.45 | $1.8M | 30,658 |
| 2025-08-13 | Wu Xiaobin President and COO | Sale 10b5-1 | −3,517 | $303.54 | $1.1M | 27,141 |
| 2025-08-13 | Wu Xiaobin President and COO | Sale 10b5-1 | −7,359 | $304.37 | $2.2M | 19,782 |
| 2025-08-13 | Wu Xiaobin President and COO | Sale 10b5-1 | −528 | $305.59 | $161K | 19,254 |
| 2025-08-13 | Wu Xiaobin President and COO | Sale 10b5-1 | −9,637 | $306.74 | $3.0M | 9,617 |
| 2025-08-13 | Wu Xiaobin President and COO | Sale 10b5-1 | −9,617 | $307.38 | $3.0M | 0 |
| 2025-08-13 | Wu Xiaobin President and COO | Option exercise · Share Option (Right to Buy) 10b5-1 | −296,049 | 0 | ||
| 2025-08-13 | Wu Xiaobin President and COO | Option exercise · Share Option (Right to Buy) 10b5-1 | −352,105 | 709,709 | ||
| 2025-08-13 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −1,112 | $300.00 | $334K | 0 |
| 2025-08-13 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +4,381 | $194.47 | $852K | 4,381 |
Page 21 of 71 · 1,406 trades